Reemergent Cases of COVID-19 — Dalian City, Liaoning Province, China, July 22, 2020
Xiang Zhao(Guangdong Polytechnic Normal University), Wenqing Yao(Tsinghua University), Jianqun Zhang(Shenyang Center for Disease Control and Prevention), Tianjiao Ji(National Health and Family Planning Commission), Hong Wang(Nanjing Forestry University), Ji Wang(Zhejiang Lab), Yong Zhang(Eisai (Japan)), Zhijian Bo, Dayan Wang(Sun Yat-sen University), Jinbo Xiao(National Institute for Viral Disease Control and Prevention), Qian Yang(National Institute for Viral Disease Control and Prevention), Wenbo Xu(Shenyang Institute of Automation), Cao Chen(Nanjing Medical University), Lingling Mao(Jiangsu University), Yang Song(National Institute for Viral Disease Control and Prevention)
Cited by 34
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818